Presentations

Lexeo Corporate Presentation – January 2026 1.9 MB

Interim Clinical Data from the Phase 1/2 HEROIC-PKP2 Trial of LX2020 for Arrhythmogenic Cardiomyopathy Caused by Mutations in the PKP2 Gene Presentation 1.6 MB

Interim Phase 1/2 Clinical Data of LX1001 for the Treatment of APOE4-Associated Alzheimer’s Disease – October 2024 1.3 MB